Literature DB >> 2056065

Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a noncapsular exoantigen.

A J Hamilton1, M A Bartholomew, J Figueroa, L E Fenelon, R J Hay.   

Abstract

Three monoclonal antibodies (MAbs), designated 7C5, 7C9, and 5G8, against a cytoplasmic antigen of Cryptococcus neoformans were produced. MAbs 7C5 and 7C9 recognize culture filtrate antigen (exoantigen) of both encapsulated and nonencapsulated isolates of this pathogen, which suggests that they do not recognize capsular polysaccharide material. This is supported by immunofluorescence data which show reactivity of all 3 MAbs to cytoplasm and cell membranes only. MAb 7C9 also recognized C. neoformans var. gattii antigens but no other fungal pathogens tested in an enzyme-linked immunosorbent assay, while 7C5 and 5G8 recognized antigens of the cross-reactive pathogen Trichosporon beigelii but did not recognize either C. neoformans var. gattii isolates or any other fungal antigens. By Western blot (immunoblot), 7C9 detected antigen at 110 to 120, 65 to 70, 45 to 50, and 36 to 38 kDa; in addition to the latter band, the other two MAbs recognized a band at approximately 30 kDa. All three MAbs were of the immunoglobulin G1 subclass. The two MAbs which are capable of reacting with noncapsular culture supernatant antigen have possible uses in serodiagnosis, particularly in AIDS patients infected with C. neoformans, since in this group the present latex agglutination test has some limitations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056065      PMCID: PMC269919          DOI: 10.1128/jcm.29.5.980-984.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

3.  Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection.

Authors:  C K Campbell; A L Payne; A J Teall; A Brownell; D W Mackenzie
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

4.  Diagnostic value of cryptococcal antigen in the cerebrospinal fluid of patients with malignant disease.

Authors:  R L Hopper; E V Perry; V Fainstein
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

5.  Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

Authors:  S M Read; D H Northcote
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

6.  Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies.

Authors:  W D Matthew; A W Sandrock
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

7.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital.

Authors:  E Prevost; R Newell
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

9.  Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.

Authors:  J W Murphy; J W Moorhead
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Phosphorylcholine-bearing antigens in filarial nematode parasites: analysis of somatic extracts, in-vitro secretions and infection sera from Brugia malayi and B. pahangi.

Authors:  R M Maizels; J Burke; D A Denham
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

View more
  10 in total

1.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: new strategies for detection of circulating antigens.

Authors:  B L Gómez; J I Figueroa; A J Hamilton; B Ortiz; M A Robledo; R J Hay; A Restrepo
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  An opsonizing monoclonal antibody that recognizes a noncapsular epitope expressed on Cryptococcus neoformans.

Authors:  G J Merkel; B A Scofield
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 5.  Challenges in Serologic Diagnostics of Neglected Human Systemic Mycoses: An Overview on Characterization of New Targets.

Authors:  Moisés Morais Inácio; Vanessa Rafaela Milhomem Cruz-Leite; André Luís Elias Moreira; Karine Mattos; Juliano Domiraci Paccez; Orville Hernandez Ruiz; James Venturini; Marcia de Souza Carvalho Melhem; Anamaria Mello Miranda Paniago; Célia Maria de Almeida Soares; Simone Schneider Weber; Clayton Luiz Borges
Journal:  Pathogens       Date:  2022-05-11

6.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera.

Authors:  A J Hamilton; J Goodley
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope.

Authors:  A J Hamilton; L Jeavons; P Hobby; R J Hay
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

9.  Production of specific monoclonal antibodies to Aspergillus species and their use in immunohistochemical identification of aspergillosis.

Authors:  L E Fenelon; A J Hamilton; J I Figueroa; M A Bartholomew; M H Allen; P McCarthy; R J Hay
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

10.  Recognition of fibronectin by Penicillium marneffei conidia via a sialic acid-dependent process and its relationship to the interaction between conidia and laminin.

Authors:  A J Hamilton; L Jeavons; S Youngchim; N Vanittanakom
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.